CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Medimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 2, 2024Binding Molecules Specific For Cd73 And Uses Thereof2
Oct 5, 2022Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy1
Jul 7, 2021Interleukin-13 Antibody Composition1
Mar 31, 2021Methods For Treating Hepcidin-Mediated Disorders1
Mar 3, 2021Purification Of Recombinantly Produced Polypeptides2
Feb 17, 2021Pyrrolobenzodiazepines And Conjugates Thereof1
Mar 1, 2017Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders1

Top competitors of Medimmune

List of top competitors of Medimmune based on patent oppositions.